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Abstract 
 
Objective. Increased adipose production of 4-hydroxynonenal (4-HNE), a bioreactive 
aldehyde, directly correlates with obesity and insulin resistance.  The aim of this study 
was to elucidate the impact of 4-HNE in mediating adipocyte differentiation and function 
in two metabolically distinct obese groups; the insulin sensitive (IS) and the insulin 
resistant (IR).  
Methods. Subcutaneous (SC) adipose tissues were obtained from eighteen clinically well 
characterized obese premenopausal women undergoing weight reduction surgery. 
Cellular distribution of 4-HNE in the form of protein adducts was determined by 
immunohistochemistry in addition to its effect on oxidative stress, cell growth, 
adipogenic capacity and insulin signaling in preadipocytes derived from the IS and IR 
participants. 
Results. 4-HNE was detected in the SC adipose tissue in different cell types with the 
highest level detected in adipocytes and blood vessels. Short and long-term in vitro 
treatment of SC preadipocytes with 4-HNE caused inhibition of their growth and 
increased production of reactive oxygen species (ROS) and antioxidant enzymes. 
Repeated 4-HNE treatment led to a greater reduction in the adipogenic capacity of 
preadipocytes from IS subjects compared to IR and caused dephosphorylation of IRS-1 
and p70S6K while activating GSK3α/β and BAD, triggering an IR phenotype.  
Conclusion. These data suggest that 4-HNE-induced oxidative stress plays a role in the 
regulation of preadipocyte growth, differentiation and insulin signaling and may therefore 
contribute to adipose tissue metabolic dysfunction associated with insulin resistance.  
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Introduction 
 
Obesity constitutes a major health problem in developed countries, and is increasingly 
becoming one in the developing world. However, a subset of obese individuals, known as 
the insulin sensitive (IS) obese or metabolically healthy obese (MHO), maintain insulin 
sensitivity and exhibit less metabolic abnormalities than their equally obese insulin 
resistant (IR) counterpart [1, 2]. The transient nature of the protective phenotype of IS 
obesity, which may shift towards a more adaptable insulin resistant (IR) obesity over 
time, was previously suggested [3].  
 
Obesity causes subcutaneous (SC) fat dysfunction, leading to a reduction in the number 
of differentiating preadipocytes and hypertrophy of mature adipocytes, predisposing 
adipose tissue to insulin resistance [4-6]. Obesity-associated insulin resistance is marked 
by impaired SC adipogenesis while IS obese individuals exhibit a more efficient 
adipogenesis [7]. This contributes to the expansion of visceral fat in IR obese subjects 
with ectopic fat deposition in the liver, skeletal muscle and other depots such as 
epicardial fat [8], causing further augmentation of IR in these tissues [9].  
 
Fat accumulation within the adipose tissue correlates with markers of systemic oxidative 
stress as an early mediator of metabolic syndrome [10]. Increased production of reactive 
oxygen species (ROS) in the adipose tissue causes lipid peroxidation and tissue 
dysfunction [10]. One of the ROS main targets are polyunsaturated fatty acids (PUFAs) 
that are esterified in the membrane or storage lipids [11]. PUFA-derived reactive 
aldehydes have an important role in cellular signaling, proliferation and differentiation, 
both under physiological as well as pathological conditions [12, 13]. 4-hydroxynonenal 
(4-HNE) is the most abundant lipid peroxidation product of arachidonic acid and a key 
mediator of oxidant-induced cell signaling and apoptosis [14]. The cellular concentration 
of 4-HNE varies from 0.1 to 0.3 µM under physiological conditions and from 10 µM up 
to 5 mM under oxidative stress [15, 16]. Differences in the redox status and increased 4-
HNE levels of human adipose tissues in relation to obesity and metabolic risk were 
previously reported [17]. This elevation can progressively impair cell structure and 
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function due to the accumulation of stable adducts formed with proteins, phospholipids 
and DNA [18, 19]. The generation of high levels of 4-HNE has been associated with 
inflammatory processes [20-22] through the activation of cyclooxygenase [23], under 
pathological conditions such as insulin resistance, atherosclerosis and obesity [24]. 
 
Increased intracellular 4-HNE accumulation in adipose tissues contributes to obesity-
related lipolytic activation [25]. The role of 4-HNE on impairment of adipocyte 
differentiation was shown in 3T3L1 murine preadipocytes, where short-term as well as 
repeated exposure of these cells to physiological concentrations of 4-HNE promoted 
subsequent oxidative stress, impaired adipogenesis, alteration of the expression of 
adipokines, increased lipolytic gene expression and free fatty acids release [26]. These 
effects were suggested more recently to be mediated by a decrease in aldehyde 
dehydrogenase 2 activity [27].  
 
In the present study, we hypothesize that in vitro long-term exposure of SC preadipocytes 
from IS individuals to 4-HNE can impair their adipogenesis and insulin sensitivity, 
rendering their behavior like that seen in preadipocytes from IR individuals. 
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Materials and methods 
 
Materials 
IL-6 and leptin ELISAs were purchased from R&D systems (UK) and Insulin ELISA 
from Mercodia Diagnostics (Sweden). 3,3' Diaminobenzidine tetrahydrochloride  and 
LSAB kit were obtained from DAKO (Denmark). OxiSelect hydrogen 
peroxide/peroxidase assay kit was obtained from Cell Biolabs (UK). DAPI and 
LipidTOX™ Green Neutral Lipid were purchased from Life Technologies 
(UK).  Nitrocellulose membranes were obtained from Amersham (UK). Secondary 
antibody solution EnVision and 3,30-diaminobenzidine tetra-hydrochloride were 
purchased from Dako (Denmark). Human 4-HNE ELISA kit (CSB-E16214h) was 
purchased from Cusabio (China). RNAeasy extraction kit, first strand cDNA synthesis kit 
and RT2 Profiler human insulin resistance PCR arrays were from Qiagen (UK). 
Milliplex(r) Map Human Panel Oxidative stress Magnetic Bead Panel (H0XSTMAG-
18K) was purchased from Millipore (UK) and Bio-Plex Pro™ Cell Signaling Akt Panel, 
8-plex (LQ00006JK0K0RR) from Bio-Rad (UK). Other chemicals and reagents were 
purchased from Sigma (Germany) unless indicated otherwise.  
 
Cohort 
Eighteen obese and morbidly obese premenopausal females were recruited among 
patients undergoing weight reduction surgery at Hamad Medical Corporation (HMC) in 
Doha, Qatar. All participants provided informed consents before surgery. All protocols 
were approved by the Institutional Research Boards of ADLQ and HMC (SCH-ADL-
070, SCH-JOINT-111). Anthropometric and plasma measures were determined as 
described previously [7], including systolic (SBP),  diastolic blood pressure (DBP), mean 
arterial blood pressure (MAP), low density lipoprotein (LDL), high density lipoprotein 
(HDL), total cholesterol, triglycerides, fasting plasma glucose (FPG), IL-6, Leptin, 
insulin, alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine 
transaminase (ALT), bilirubin, and total protein. Insulin resistance was calculated by the 
homeostatic model assessment (HOMA-IR) [28] using 2.4 as a cutoff point (30th 
percentile). Accordingly, subjects were dichotomized into IS (HOMA-IR < 2.4, 9 
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subjects) and non-diabetic IR (HOMA-IR > 2.4, 9 subjects). SC adipose tissues of 1 to 5 
g biopsies were collected from all participating subjects during their surgeries and were 
immediately transported to laboratory for processing.  
 
Immunohistochemical analysis of 4-HNE 
Ten adipose tissue samples were randomly selected for immunohistochemical analysis. 
Adipose tissue biopsies were formalin-fixed and paraffin-embedded. Sections made from 
paraffin blocks were stained with Hematoxylin/Eosin (HE). 4-HNE staining was 
performed using our genuine monoclonal antibody specific for HNE-histidine [29, 30]. 
Monoclonal antibody was obtained from the culture medium of the clone derived from a 
fusion of Sp2-Ag8 myeloma cells with B-cells of a BALBc mouse immunized with HNE 
modified keyhole limpet hemocyanine [29]. The clone 1g4h7 TC antibody is specific for 
the HNE-histidine epitope in HNE-protein (peptide) conjugates. The dot-blot 
immunochemistry was used to verify the efficiency of monoclonal antibody used for 
detection of 4-HNE- His adducts by immunohistochemistry. Briefly, the 5% solution of 
BSA containing final concentrations of 4-HNE ranging from 1 to 100 µM were used for 
comparison to the control BSA solution without 4-HNE. Two hundred microliters of thus 
prepared solutions were spotted onto nitrocellulose membranes. Each membrane was 
incubated in blocking solution (2% non-fat milk powder in phosphate buffer) at room 
temperature for 60 min and subsequently incubated overnight with mouse monoclonal 
antibodies against 4-HNE-His adducts. The membranes were afterwards washed and 
incubated for 30 min with the secondary antibody solution EnVision diluted 1:25 in PBS. 
Immune complexes were visualized using 3,30-diaminobenzidine tetra-hydrochloride 
staining. 
For the immunohistochemical detection of the HNE-protein adducts the 
immunoperoxidase technique was used using EnVision kit (Dako, Denmark) as described 
previously [31]. Briefly, first step included 2 hours incubation with monoclonal anti-HNE 
antibody (dilution 1:10) while the other two steps were performed using EnVision kit 
according to manufacturers’ instructions. 3,3' Diaminobenzidine tetrahydrochloride was 
used as a chromogen in the HE counterstained sections. Immunohistochemical 
investigation of HNE positivity was determined by an experienced pathologist without 
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prior knowledge of the experimental groups and scored in a semiquantitative way 
described before and often used for clinical studies [32] (- 0% positive cells, + <5% 
positive cells, ++ 5-25% positive cells, +++ 25-50% positive cells, ++++ >50% positive 
cells). The presence of HNE-protein adducts in adipocytes, connective tissues, 
inflammatory cells and blood vessels was defined as negative (-) in the absence of the 
HNE-protein adducts, or as low positive (+, ++) or high positive (+++, ++++) in the 
presence of the HNE-protein adducts [33].  
 
Isolation of stromal-vascular fraction cells from human SC adipose tissues 
Stromal-vascular fraction (SVF) was obtained by collagenase digestion as previously 
described [34].  The SVF pellet was re-suspended in stromal medium (DMEM-F12, 10% 
FBS, Pen/Strep) and maintained in a humidified incubator at 37 °C with 5% CO2 until 
confluence, then passaged at 4x104/cm2 when necessary. 
 
4-HNE preparation 
The aldehyde was obtained in the form of 4-Hydroxynonenal-dimethylacetal. Prior to the 
experiment it was activated with 1 mM cold HCl for 1 hour at 4°C. For the experiment 
HNE was diluted in DMEM-F12 medium.  
 
Proliferation assay 
Cells (passage 1-5) were grown in medium (DMEM-F12, Pen/Strep) containing 3% FBS 
in the absence or presence of different concentrations of 4-HNE ranging from 2.5-40µM 
for 4 days. Cells were then fixed with formalin for 10 min, stained with 4′,6-Diamidino-
2-phenylindole dihydrochloride (DAPI) and total nuclei number quantified by ArrayScan 
XTI (Thermo Scientific).  
 
Differentiation assays 
Cells (passage 1-5) were either grown in differentiation medium (DMEM-F12, 3% FBS, 
33 μM bioten, 17 μM d-pantothenate, 1 μM dexamethasone, 250 μM of 
methylisobutylxanthine, 0.1 μM human insulin, 5 μM of PPARγ agonist, rosiglitazone) in 
the presence or absence of 5 or 10 μM of 4-HNE for 7 days, followed by 7 days 
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incubation in maintenance medium containing the same components as the differentiation 
medium except for methylisobutylxanthine and rosiglitazone as described previously 
[35]. To determine differentiation capacity, cells were fixed with 4% formalin for 10 min, 
stained with DAPI and subsequently with HCS Lipidtox for 20 min. Total number of 
nuclei (DAPI) and differentiated adipocytes (Lipidtox positive cells) were scored by 
ArrayScan XTI (Thermo Scientific) using spot detection module. Differentiation capacity 
was assessed by calculating the ratio of Lipidtox positive cells/total number of stained 
nuclei and presented as a percentage (differentiation capacity).  
 
Measuring endogenous 4-HNE protein adduct levels in preadipocyte cultures 
Paired cultures of proliferating and differentiating preadipocytes were lysed and 
endogenous 4-HNE levels were measured in 85µg protein lysates using human 4-HNE 
ELISA according to manufacture’s instructions.   
 
Gene expression analysis of sterol regulatory element binding transcription factor 1 
(SREBF1), fatty acid synthase (FASN) and Fatty acid-binding protein 4 (FABP4) in 
response to 4-HNE treatment 
Preadipocytes were treated with 10µM 4-HNE every three days for the entire 
differentiation period. RNA was extracted using RNAeasy kit and cDNA was synthesized 
using first strand cDNA synthesis kit according to manufacturer’s instructions. 
RT2 Profiler human insulin resistance PCR arrays were used to simultaneously examine 
the mRNA levels of 89 genes, including five "housekeeping genes" in 96-well plates 
according to manufacturer’s protocol. Genes included Sterol Regulatory Element Binding 
Transcription Factor 1 (SREBF1), fatty acid synthase (FASN) and Fatty acid-binding 
protein 4 (FABP4). Data were normalized with the internal housekeeping genes and 
ΔΔCt was calculated using ΔCt from proliferating IS-SC as the control group according 
to manufacturer’s protocol. 
 
Adipocyte oxidative stress assay in response to 4-HNE treatment 
Intracellular ROS production was evaluated using 2',7'-dichlorfluorescein-diacetate 
(DCFH-DA, Fluka) probe as previously described [36]. Briefly, cells were pretreated 
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with 10 µM DCFH-DA in the HBSS in 5% CO2 / 95% air at 37°C for 30 min followed 
by removal of excess probe and treatment with 5 and 10uM of 4-HNE in stromal medium 
with 3% FBS. The fluorescence intensity was measured continuously throughout 12 
hours using TECAN Infinite M200 PRO plate reader equipped with gas control mode to 
maintain 37°C and 5% CO2, with an excitation wavelength of 500 nm and emission 
detection at 529 nm. The arbitrary units, relative fluorescence units (RFU), were based 
directly on fluorescence intensity. Intracellular ROS production was also evaluated using 
aminotriazole assay as described previously [37] using OxiSelect hydrogen 
peroxide/peroxidase assay kit following 12 hours of 10µM 4-HNE treatment according to 
manufacturer’s instructions. 
 
Cellular antioxidant defense systems analyses in response to 4-HNE treatment 
The effect of 4-HNE treatment on the levels of antioxidant proteins in human 
preadipocytes was quantified following 1, 4 and 15 days of treatment. Briefly, 
preadipocytes were treated with 10µM of 4-HNE one day post-seeding for one day 
(baseline levels), 4 days (proliferation) or 15 days (differentiation), then lysed and 
assayed using a commercial human 5-plex Milliplex(r) Map Human Panel Oxidative 
stress Magnetic Bead Panel (H0XSTMAG-18K) kit following manufacturer’s 
instructions. The panel included catalase, thioredoxin (TRX1), superoxide dismutase 1 
(SOD1), superoxide dismutase 2 (SOD2) and peroxiredoxin 2 (PRX2).  The assay was 
performed using Luminex xMAP technology (Merck Millipore) following 
manufacturer’s instructions. 
 
Insulin signaling analysis in response to 4-HNE treatment 
The effect of 4-HNE treatment on the phosphorylation of IRS-1 (Ser636/Ser639), p70 S6 
kinase (Thr389), GSK-3α/β (Ser21/Ser9) and p70 S6 kinase (Thr389) was quantified in 
human preadipocytes from IS and IR individuals. Briefly, preadipocytes were treated 
with 10µM of 4-HNE one day post-seeding for 15 days then lysed. Equal volumes of 
lysates were assayed using a commercial Bio-Plex Pro™ Cell Signaling Akt Panel 
following manufacturer’s instructions.  
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Statistical analysis 
Data are presented as mean±standard deviation (SD) for parametric data, median 
(interquartile range, IQ) for non-parameteric data in table 1 and mean±SEM in figures. 
Comparisons were performed with t-test, Wilcoxon–Mann–Whitney, 1-way ANOVA, or 
Linear regression model as appropriate using IBM SPSS statistics 21.  
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Results 
 
General characteristics of study population 
Eighteen obese and morbidly obese (BMI 43.2±5.09 kgm-2) young (30.4 ±8.3 years) 
females were recruited from amongst patients undergoing weight reduction surgery at 
HMC (Table 1). Participating subjects exhibited hypercholesterolaemia (4.8±0.96mM/L), 
hyperleptinemia (49.8±18.4 ng/ml) and hyperinsulinemia [11.4 (7.7-19.1) mIU/L] and 
were dichotomized into IS and IR groups based on their HOMA-IR index. Compared to 
age and BMI-matched IS subjects, IR individuals had higher levels of total cholesterol 
[4.3 (0.9) vs 5.2 (0.9), p=0.04] and ALT [20.1 (16-25) vs 32.4 (21.5-49), p=0.05] (Table 
1).  
 
Variables Cohort (n=18) IS  (N=9) IR (N=9) p value 
Age (year) 30.4 (8.3) 32 (10.7) 28.5 (4.5) 0.4 
BMI (kg.m-2) 43.2 (5.09) 41.2 (1.9) 45.4 (6.6) 0.08 
SBP (mmHg) 117.5 (39.35) 105.1 (40.3) 131.4 (35.4) 0.18 
DBP (mmHg) 70.4 (10.9) 68.5 (9.2) 72.4 (12.8) 0.5 
MAP 88.6 (13.45) 85.1 (8.3) 92.1 (17.03) 0.3 
Cholesterol (mmol/L) 4.7 (0.96) 4.3 (0.9) 5.2 (0.9) 0.04 
LDL (mmol/L) 3.2 (0.99) 2.8 (0.7) 3.6 (1.1) 0.09 
Triglyceride (mmol/L) 1.1 (0.8-1.5) 0.9 (0.7-1.2) 1.4 (0.78-1.9) 0.12 
Triglyceride/HDL 2.4 (1.4-3.4) 2.1 (1.2-2.3) 2.7 (1.2-2.3) 0.18 
HDLC (mmol/L) 1.2 (0.2) 1.1 (0.3) 1.2 (0.2) 0.47 
Leptin (ng/ml) 49.8 (18.4) 56.7 (19.1) 42.8 (15.5) 0.1 
IL-6 (pg/ml) 3.2 (1.8) 2.8 (1.4) 3.6 (2.1) 0.32 
FBG (mmol/L) 5.1 (0.6) 5.0 (0.6) 5.1 (0.6) 0.58 
Insulin (mIU/L) 11.4 (7.7) 6.2 (2.9) 16.6 (7.5) 0.001 
HOMA-IR  2.5 (1.7) 1.3 (0.6) 3.7 (1.5) 0.001 
Albumin (g/L) 42.4 (5.6) 40.8 (4.9) 44.7 (6.7) 0.411 
ALP (IU/L) 76.5 (61-92.5) 84.9 (65-104.5) 67 (48.2-78.5) 0.09 
ALT (IU/L) 26.3 (17-33) 20.1 (16-25) 32.4 (21.5-49) 0.05 
AST (IU/L) 20.1 (15.5-26.5) 17.4 (15-19) 23 (16-28.5) 0.07 
Billirubin (μmol/L) 10.5 (4.8) 9.1 (3.7) 11.889 (5.5) 0.23 
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Table 1. General characteristics of participants. Obese and morbidly obese premenopausal female patients 
undergoing weight reduction surgery were dichotomized into two groups [insulin sensitive (IS) and insulin 
resistant (IR)] based on their homeostatic model assessment of insulin resistance (HOMA-IR) index.  
Components of metabolic syndrome were measured in IS and IR including BMI (body mass index), SBP 
(systolic blood pressure), DBP (diastolic blood pressure), MAP (mean arterial blood pressure), LDL (low 
density lipoprotein), HDL (high density lipoprotein), FPG (fasting plasma glucose), HOMA-IR, ALP 
(alkaline phosphatase), ALT (alanine transaminase), AST (aspartate aminotransferase). Data are presented 
as mean (SD) or median (IQR). Differences were tested by independent sample t test or Mann Whitney u 
test, P<0.05.  
 
Characterization of 4-HNE staining in various cell types of the SC adipose tissue 
from obese patients 
To confirm presence of 4-HNE stable adducts in adipose tissues, accumulation of 4-HNE 
in components of adipose tissues including adipocytes, connective tissues, blood vessels 
and inflammatory cells was analysed by immunohistochemistry (IHC) in all tested 
samples by 4-HNE antibody specific to Histidine epitope (data not shown). The strongest 
staining of 4-HNE stable adducts was detected in adipocytes and blood vessels; medium 
staining was in inflammatory cells and weakest staining was in connective tissues 
(Figure1). There were no significant differences in 4-HNE staining between IS and IR-
adipose tissues confirming previous report [17]. 
14 
 
 
Figure1. 4-HNE IHC staining in SC adipose tissues from obese patients. Sections from ten adipose tissues 
were stained with for HNE-His and semi-quantified in adipocytes (A), inflammatory cells (B), connective 
tissues (C) and blood vessels (D) by an experienced pathologist without prior knowledge of the 
experimental groups.  
 
Measurement of endogenous 4-HNE accumulation in proliferating and 
differentiating preadipocytes 
The presence of 4-HNE adducts in paired cultures of proliferating preadipocytes and 
differentiated adipocytes was investigated. Detectable concentrations were quantified in 
both cultures with 30% increase in differentiated adipocytes compared to proliferating 
preadipocytes, possibly as a consequence of lipid accumulation with differentiation. IR 
differentiating preadipocytes exhibited 20% increase in 4-HNE accumulation than their 
IS counterparts (Figure 2).  
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 Figure 2. Endogenous 4-HNE accumulation in proliferating and differentiating preadipocytes. Levels of 
accumulated 4-HNE adducts were quantified in equal concentrations of protein lysates from paired cultures 
of proliferating preadipocytes and differentiated adipocytes from IS and IR individuals. Data are presented 
as Mean±SEM. N=15 (5 IS and 10 IR), *P<0.05, paired and independent sample t-test.  
 
Preadipocyte proliferation, ROS generation and levels of ROS scavenging enzymes 
in response to 4-HNE treatment 
The effect of exogenous 4-HNE treatment on preadipocytes growth and differentiation is 
shown in Figure 3. Treatment of preadipocytes with 4-HNE for 4 days exhibited a 
concentration-dependent inhibition of proliferation at a range of 2.5-20µM, compared to 
their untreated control, with higher concentrations causing cell death (Figure 3A). Acute 
treatment of preadipocytes with 10µM 4-HNE for 12 hours caused 2-4 folds elevated 
intracellular ROS and steady state hydrogen peroxide production compared to untreated 
cells (p<0.05, Figure 3B, C).  It also increased levels of ROS scavenging enzymes 
including catalase, TRX1, PRX2, SOD1 and SOD2 (Figure 3D). Elevated levels of ROS 
scavenging enzymes were maintained following multiple exposures to 10µM of 4-HNE 
for 15 days, except for mitochondrial SOD2 activity (Figure 3E). When treated cells were 
dichotomized into IS and IR, there were no differences in levels of ROS scavenging 
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enzymes in response to short-term (Figure 3F) nor to long-term 4-HNE treatment except 
for catalase which exhibited a significantly higher elevation in IS differentiating 
preadipocytes compared to IR-derived counterparts (Figure 3G). 
 
Figure 3. Effect of 4-HNE on SC preadipocytes proliferation and oxidative stress. Proliferation of 
preadipocytes upon acute exposure to different concentrations of 4-HNE was quantified by automated 
counting of cell number by DAPI staining (A). Reactive oxygen species (ROS) production was measured in 
response to 10 µM 4-HNE for up to 12 hours compared to untreated (UT) (B). Intracellular levels of 
hydrogen peroxide measured 12 hours upon 10 µM 4-HNE exposure compared to untreated (UT) (C). 
Levels of ROS scavenging enzymes (catalase, Trx1, Prx2, SOD1 and SOD2) in response to acute (12 
hours, single exposure) (D) and Long-term (15 days, repeated exposures) treatment of preadipocytes to 10 
µM 4-HNE (E). Comparison of levels of ROS scavenging enzymes between insulin sensitive (IS) and 
insulin resistant (IR)-derived preadipocytes in response to acute (F) and long-term exposures (G). Data are 
presented as Mean±SEM in A-E and as median (interquartile range) in F and G. N=18 (9 IS and 9 IR), 
*P<0.05, ANOVA and paired samples T-Test. 
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Growth and differentiation of IS vs IR preadipocytes in response to 4-HNE 
treatment 
The effect of long-term treatment with 10µM of 4-HNE on preadipocyte growth and 
differentiation in IS and IR cells is presented in Figure 4. Exposure to multiple doses of 
4-HNE led to reduction in growth and differentiation of preadipocytes in both groups 
(Figure 4A), marked by upregulation of anti-adipogenic FABP4 and down regulation of 
the adipogenic FASN and SREBF1 genes (Figure 4B). Whereas comparable levels of 
inhibition of cellular growth in response to 4-HNE were detected between IS and IR 
preadipocytes (Figure 4C), 4-HNE had a stronger inhibitory effect on IS-preadipocytes 
differentiation (p<0.01) compared to IR with a mean difference of 25.9% (IQR 3.9-55.7) 
(Figure 4D).   
 
Figure 4. Effect of 4-HNE treatment on cellular growth and adipogenic capacity of preadipocytes derived 
from insulin sensitive and insulin resistant individuals. Total number of nuclei  and number of 
differentiating preadipocytes from insulin sensitive (IS) and insulin resistant (IR) patients in response 
10µM of 4-HNE  was quantified by automated scoring of the number of nuclei (DAPI staining) and 
percentage of lipidtox positive cells to total number of cells (adipogenic capacity) by ArrayScan XTI 
Reader. Representative images of differentiated adipocytes with the selected fluorescently labelled lipid 
droplets are shown (A). FABP4, FASN and SREBF1 gene expression fold change in response to HNE 
treatment are shown (B). Percentages of inhibition of cellular growth (C) and adipogenic capacity (D) 
18 
 
compared to untreated controls were compared between IS and IR-derived cells. Data are presented as 
Mean±SEM. N=18 (9 per group).*P<0.05, Independent samples T-Test. 
 
Analysis of insulin signaling in IS vs IR preadipocytes in response to 4-HNE 
treatment 
Differences in insulin signaling pathway were detected between IS and IR preadipocytes 
in response to long-term treatment with 10µM of 4-HNE (Figure 5). IR-derived 
preadipocytes exhibited lower levels of phosphorylated IRS-1 and 70S6K at baseline 
compared to IS (Figure 5A and 5B), confirming their resistance to insulin action. Long-
term treatment of preadipocytes from IS subjects to 10µM of 4-HNE caused significant 
dephosphorylation of IRS-1 (Figure 5A) and 70S6K (Figure 5B) and activation of 
GSK3α/β (Figure 5C) and BAD (Figure 5D), indicating development of IR phenotype. 
On the other hand, 4-HNE treatment of preadipocytes from IR subjects did not cause 
significant changes in the activation levels of IRS-1, 70S6K, GSK3α/β or BAD, 
suggesting their adaptation to 4-HNE action. 
 
Figure 5. Effect of 4-HNE on insulin signaling in differentiating preadipocytes derived from insulin 
sensitive (IS) and insulin resistant (IR) individuals. Levels of phosphorylated IRS-1 (A), 70S6K (B), 
GSK3α/β (C) and BAD (D) were measured following long-term treatment of differentiating preadipocytes 
from IS and IR subjects to 10µM of 4-HNE. Data are presented as Mean±SEM. *P<0.05, Independent and 
paired samples T-Test. N=18 (9 per group).  
19 
 
 
Discussion 
 
The lipid peroxidation product 4-HNE is one of the key mediators of oxidant-induced cell 
signaling and apoptosis [14], as it activates antioxidant defense systems at lower 
concentrations, while causes increased cell death with higher concentrations [38]. 
Therefore physiological levels of 4-HNE (up to 10 µM) in adipose tissues play a crucial 
role in redox homeostasis, whereas elevated 4-HNE levels (above 10 µM) can cause 
adipocyte dysfunction and insulin resistance [26, 39]. This study reports for the first time 
that long-term treatment of human primary preadipocytes from SC adipose tissues 
obtained from obese subjects with physiological concentrations of 4-HNE causes 
increased oxidative stress, inhibition of cell growth, loss of adipogenic capacity and 
induction of insulin resistance. The study also reports that preadipocytes from IS subjects 
are more prone to the effects of 4-HNE treatment than their IR counterpart. The 
heterogeneity in the sensitivity of SC preadipocytes to 4-HNE with regard to 
adipogenesis and insulin resistance in obese subjects may reflect the transient status of IS 
obesity that can change into a more adaptable IR phenotype over time.  
 
Emerging data initially showed that elevated levels of 4-HNE in SC adipose tissues are 
located mainly within adipocytes and blood vessels in comparable levels between IS and 
IR subjects. Similar levels of 4-HNE between IS and IR adipose tissues, as reported 
previously [17], do not necessarily reflect a similar duration of exposure to 4-HNE as it 
may merely represent a snapshot of a long processes that preceded the onset of obesity. 
Indeed, this report shows that spontaneously accumulated levels of 4-HNE adducts are 
higher in cultured differentiating IR-preadipocytes compared to a similar age IS cultures, 
perhaps as a result of increased ROS production in IR preadipocytes as we reported 
previously [7]. This data indeed confirms an important biological role for 4-HNE by 
showing its spontaneous accumulation in differentiating preadipocytes that alters cellular 
redox homeostasis. 
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The data indicated that acute 4-HNE treatment of preadipocytes at a concentration that is 
at the lower end of the pathophysiological range [15], and reported previously in 3T3L-1 
preadipocytes [26], increases intracellular hydrogen peroxide as well as ROS production 
in preadipocytes in a concentration-dependent manner, which is also associated with 
increased levels of ROS scavenging enzymes including catalase, PRX2, TRX1, SOD1 
and SOD2. Acute exposure to 4-HNE had the most pronounced effect on SOD2, 
suggesting that mitochondria are important early targets for 4-HNE induced redox 
imbalance in preadipocytes. However, long-term exposure to 4-HNE highlighted the role 
of catalase, but not SOD2, as the main anti-oxidant defense mechanism in differentiating 
preadipocytes against oxidative stress mediated by repeated 4-HNE exposure (Figure 3). 
This could be one of the mechanisms triggered to enable cellular adaptation to 4-HNE-
induced intracellular H2O2 production [40]. Moreover, elevated catalase could also 
suggest changes in the lipid metabolism as it is an important enzyme in decomposing 
H2O2 produced during beta oxidation of fatty acids by flavin adenine dinucleotide (FAD)-
oxidases [41]. The increased catalase activity in 4-HNE treated differentiating 
preadipocytes was more significant in IS-derived cells, suggesting higher sensitivity to 4-
HNE-induced oxidative stress, compared to IR-derived counterparts. Taken together, our 
data confirm both earlier in vitro findings of increased ROS production in response to 4-
HNE in 3T3L-1 preadipocyte cell line [26] and in vivo observations of elevated ROS 
scavenging enzymes in adipose tissues from obese subjects with increased 4-HNE levels 
[17], adding to the significant role 4-HNE plays in modulating adipose tissue 
homeostasis.  
 
Long-term treatment of SC preadipocytes with a physiological concentration of 4-HNE 
lowered adipogenesis in preadipocytes obtained from both IS and IR individuals, with a 
greater inhibition in IS-derived preadipocytes (Figure 4). The important role of 4-HNE in 
adipogenesis is further supported by gene expression studies of transcriptional regulation 
of adipocyte differentiation pathway. Key adipogenic genes including pro-adipogenic 
genes SREBF1 [42, 43] and FASN [44] were down regulated and anti-adipogenic gene 
FABP4 [45] known to play a role in fatty acid uptake, transport and metabolism was 
upregulated [46]. The lower susceptibility of IR preadipocytes to 4-HNE damaging effect 
21 
 
may suggest that IR preadipocytes have reached a certain degree of adaptation to 
oxidative stress damage as they developed resistance to insulin.  Indeed we have 
observed that, in response to elevated 4-HNE, IR preadipocytes have higher expression of 
FABP4 compared to IS preadipocytes (data not shown). In addition to its anti-adipogenic 
role, FABP4 is a known cellular target [47] and a scavenger of 4-HNE [48]. The IS 
preadipocytes, on the other hand, were still sensitive to the damaging effect of 4-HNE-
induced oxidative stress that may eventually lead to metabolic complications associated 
with insulin resistance and development of T2DM.  
 
As impaired adipogenesis and subsequent ectopic lipid accumulation are associated with 
insulin resistance [49], the greater sensitivity of IS preadipocytes to 4-HNE could also 
cause impaired glucose homeostasis. Indeed, our data indicated that long-term treatment 
of IS preadipocytes with a physiological concentration of 4-HNE triggered their 
resistance to insulin by deactivating the insulin signaling components IRS1 and p70S6K 
and activating GSK3α/β and BAD that are under the negative control of Akt [50]. As 
expected, IR-preadipocytes showed no change in their insulin signaling in response to 4-
HNE treatment as they are already resistant to its actions as seen at baseline. Although 
previous reports have shown that 4-HNE can induce insulin resistance in skeletal muscle 
cells [39], this is the first report of induction of insulin resistance in human SC 
differentiating preadipocytes in response to 4-HNE. Taken together, Figure 6 depicts 
proposed actions for 4-HNE in differentiating preadipocytes. Previous studies have 
shown that abolishing 4-HNE-induced oxidative stress in 3T3L1 by pharmacological 
intervention leads to lowering inflammation-related cyclooxygenase expression [23], 
reversal of 4-HNE deleterious effects and improvement in insulin sensitivity [51]. Future 
work will focus on pharmacological intervention aimed at alleviating insulin resistance 
and oxidative stress in IR preadipocytes. 
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Figure6. A scheme representing 4-HNE actions in adipocytes, highlighting effects on ROS production, 
modulation of lipid metabolism, impairment of adipogenesis and development of insulin resistance.  
 
Conclusions 
In conclusion, this study provides novel evidence for 4-HNE-mediated inhibition of 
human preadipocytes growth, impairment of adipogenesis and induction of insulin 
resistance, thus highlighting its crucial role in the progression obesity-associated 
metabolic syndrome. The data also identifies 4-HNE as a key player in the 
pathophysiology of adipose tissue in IS obesity and potentially a therapeutic target before 
progression into IR obesity. 
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